These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 30342828)

  • 1. Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study.
    Makhado NA; Matabane E; Faccin M; Pinçon C; Jouet A; Boutachkourt F; Goeminne L; Gaudin C; Maphalala G; Beckert P; Niemann S; Delvenne JC; Delmée M; Razwiedani L; Nchabeleng M; Supply P; de Jong BC; André E
    Lancet Infect Dis; 2018 Dec; 18(12):1350-1359. PubMed ID: 30342828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of bedaquiline-resistant tuberculosis and of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis strains with rpoB Ile491Phe mutation not detected by Xpert MTB/RIF in Mozambique: a retrospective observational study.
    Barilar I; Fernando T; Utpatel C; Abujate C; Madeira CM; José B; Mutaquiha C; Kranzer K; Niemann T; Ismael N; de Araujo L; Wirth T; Niemann S; Viegas S
    Lancet Infect Dis; 2024 Mar; 24(3):297-307. PubMed ID: 37956677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel rapid PCR for the detection of Ile491Phe rpoB mutation of Mycobacterium tuberculosis, a rifampicin-resistance-conferring mutation undetected by commercial assays.
    André E; Goeminne L; Colmant A; Beckert P; Niemann S; Delmee M
    Clin Microbiol Infect; 2017 Apr; 23(4):267.e5-267.e7. PubMed ID: 27998822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
    Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM
    PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa.
    Evans J; Stead MC; Nicol MP; Segal H
    J Antimicrob Chemother; 2009 Jan; 63(1):11-6. PubMed ID: 18940875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of rpoB gene mutations in rifampicin resistant Mycobacterium tuberculosis isolates by multiple allele specific polymerase chain reaction in Puducherry, South India.
    Thirumurugan R; Kathirvel M; Vallayyachari K; Surendar K; Samrot AV; Muthaiah M
    J Infect Public Health; 2015; 8(6):619-25. PubMed ID: 26117709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Accuracy and Utility of FluoroType MTBDR, a New Molecular Assay for Multidrug-Resistant Tuberculosis.
    de Vos M; Derendinger B; Dolby T; Simpson J; van Helden PD; Rice JE; Wangh LJ; Theron G; Warren RM
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29976588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of Anyplex II MTB/MDR/XDR for detection of resistance to first and second line drugs in Mycobacterium tuberculosis.
    Pérez-García F; Ruiz-Serrano MJ; López Roa P; Acosta F; Pérez-Lago L; García-De-Viedma D; Bouza E
    J Microbiol Methods; 2017 Aug; 139():74-78. PubMed ID: 28511895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid diagnosis of pyrazinamide-resistant multidrug-resistant tuberculosis using a molecular-based diagnostic algorithm.
    Simons SO; van der Laan T; Mulder A; van Ingen J; Rigouts L; Dekhuijzen PN; Boeree MJ; van Soolingen D
    Clin Microbiol Infect; 2014 Oct; 20(10):1015-20. PubMed ID: 24890253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting mutation pattern of drug-resistant Mycobacterium tuberculosis isolates in Himachal Pradesh using GenoType(®) MTBDRplus assay.
    Thakur C; Kumar V; Gupta AK
    Indian J Med Microbiol; 2015; 33(4):547-53. PubMed ID: 26470962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of GenoType
    Karimi H; En-Nanai L; Oudghiri A; Chaoui I; Laglaoui A; Bourkadi JE; El Mzibri M; Abid M
    J Glob Antimicrob Resist; 2018 Mar; 12():63-67. PubMed ID: 28899805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
    Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
    BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug-resistant tuberculosis in panama is driven by clonal expansion of a multidrug-resistant Mycobacterium tuberculosis strain related to the KZN extensively drug-resistant M. tuberculosis strain from South Africa.
    Lanzas F; Karakousis PC; Sacchettini JC; Ioerger TR
    J Clin Microbiol; 2013 Oct; 51(10):3277-85. PubMed ID: 23884993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study.
    Ullah I; Shah AA; Basit A; Ali M; Khan A; Ullah U; Ihtesham M; Mehreen S; Mughal A; Javaid A
    BMC Infect Dis; 2016 Aug; 16():413. PubMed ID: 27519406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance comparison of four methods for detecting multidrug-resistant Mycobacterium tuberculosis strains.
    Al-Mutairi NM; Ahmad S; Mokaddas E
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):110-5. PubMed ID: 21276306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective pragmatic approach of diagnosis of multidrug-resistant tuberculosis by high-resolution melt curve assay.
    Negi SS; Singh P; Bhargava A; Chandrakar S; Gaikwad U; Das P; Behra A
    Int J Mycobacteriol; 2018; 7(3):228-235. PubMed ID: 30198501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug-resistant tuberculosis detection and characterization of mutations in
    Tripathi R; Anupurba S
    Indian J Pathol Microbiol; 2017; 60(2):239-242. PubMed ID: 28631643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of GenoType® MTBDRplus assay to assess drug resistance and mutation patterns of multidrug-resistant tuberculosis isolates in northern India.
    Maurya AK; Singh AK; Kant S; Umrao J; Kumar M; Kushwaha RA; Nag VL; Dhole TN
    Indian J Med Microbiol; 2013; 31(3):230-6. PubMed ID: 23883707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypically occult multidrug-resistant Mycobacterium tuberculosis: dilemmas in diagnosis and treatment.
    Ho J; Jelfs P; Sintchencko V
    J Antimicrob Chemother; 2013 Dec; 68(12):2915-20. PubMed ID: 23838950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.